Pharmacokinetics of meropenem in subjects with various degrees of renal impairment.

Five healthy volunteers and 18 patients with various degrees of renal impairment received 500 mg of meropenem intravenously as a 30-min infusion. Five dialysis patients were dosed 2 h prior to hemodialysis, and four of them were also dosed between hemodialysis treatments. Plasma and urine samples we...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Christensson, B A, Nilsson-Ehle, I, Hutchison, M, Haworth, S J, Oqvist, B, Norrby, S R
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1992
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC191616/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1510451/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.7.1532
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!